-
Je něco špatně v tomto záznamu ?
Current status of sentinel lymph node mapping in the management of endometrial cancer
Helena Robova, Lukas Rob, Michael Jiri Halaska, Marek Pluta, Petr Skapa
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
Grantová podpora
NT11424
MZ0
CEP - Centrální evidence projektů
NLK
ProQuest Central
od 2001-06-01 do 2014-09-30
Health & Medicine (ProQuest)
od 2001-06-01 do 2014-09-30
Public Health Database (ProQuest)
od 2001-06-01 do 2014-09-30
PubMed
23259427
DOI
10.1586/era.12.157
Knihovny.cz E-zdroje
- MeSH
- biopsie sentinelové lymfatické uzliny metody MeSH
- hysteroskopie metody MeSH
- laparoskopie metody MeSH
- lidé MeSH
- lymfadenektomie metody MeSH
- lymfatické metastázy MeSH
- nádory endometria diagnóza patologie MeSH
- prognóza MeSH
- robotika MeSH
- staging nádorů MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The prognosis of endometrial cancer (EC) is generally favorable, while lymph node status remains the most important prognostic factor. Sentinel lymph node mapping (SLNM) could help to find women in whom adjuvant therapy could be omitted. This review analyzes different techniques of injection and histopathologic elaboration of SLNM in EC. Results of studies on SLNM in ECs seem to be promising, but only a small series have been published so far. The studies are subdivided into three groups by the technique of injection (hysteroscopic, subserosal and cervical). Range of detection rate for SLNM varies from 45 to 100%. Hysteroscopic injection is not easy to learn; moreover, exact peritumoral injection in large tumors is often impossible. Subserosal administration of tracer is difficult during laparoscopic or robotic surgery. Cervical injection is quite a controversial technique because distribution of SLNs in ECs is different from cervical cancer; moreover, there is no large study using cervical injection with systematic pelvic and para-aortic lymphadenectomy.
Department of Obstetrics and Gynecology 2nd Medical Faculty Charles University Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024054
- 003
- CZ-PrNML
- 005
- 20150116155228.0
- 007
- ta
- 008
- 130703s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1586/era.12.157 $2 doi
- 035 __
- $a (PubMed)23259427
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Robova, Helena $u Department of Obstetrics and Gynecology, 2nd Medical Faculty, Charles University, Prague, Czech Republic
- 245 10
- $a Current status of sentinel lymph node mapping in the management of endometrial cancer / $c Helena Robova, Lukas Rob, Michael Jiri Halaska, Marek Pluta, Petr Skapa
- 520 9_
- $a The prognosis of endometrial cancer (EC) is generally favorable, while lymph node status remains the most important prognostic factor. Sentinel lymph node mapping (SLNM) could help to find women in whom adjuvant therapy could be omitted. This review analyzes different techniques of injection and histopathologic elaboration of SLNM in EC. Results of studies on SLNM in ECs seem to be promising, but only a small series have been published so far. The studies are subdivided into three groups by the technique of injection (hysteroscopic, subserosal and cervical). Range of detection rate for SLNM varies from 45 to 100%. Hysteroscopic injection is not easy to learn; moreover, exact peritumoral injection in large tumors is often impossible. Subserosal administration of tracer is difficult during laparoscopic or robotic surgery. Cervical injection is quite a controversial technique because distribution of SLNs in ECs is different from cervical cancer; moreover, there is no large study using cervical injection with systematic pelvic and para-aortic lymphadenectomy.
- 650 _2
- $a nádory endometria $x diagnóza $x patologie $7 D016889
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hysteroskopie $x metody $7 D015907
- 650 _2
- $a laparoskopie $x metody $7 D010535
- 650 _2
- $a lymfadenektomie $x metody $7 D008197
- 650 _2
- $a lymfatické metastázy $7 D008207
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a robotika $7 D012371
- 650 _2
- $a biopsie sentinelové lymfatické uzliny $x metody $7 D021701
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Rob, Lukas $u Department of Obstetrics and Gynecology, 2nd Medical Faculty, Charles University, Prague, Czech Republic
- 700 1_
- $a Halaska, Michael Jiri $u Department of Obstetrics and Gynecology, 2nd Medical Faculty, Charles University, Prague, Czech Republic
- 700 1_
- $a Pluta, Marek $u Department of Obstetrics and Gynecology, 2nd Medical Faculty, Charles University, Prague, Czech Republic
- 700 1_
- $a Skapa, Petr $u Department of Pathology and Molecular Medicine, 2nd Medical Faculty, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00174405 $t Expert review of anticancer therapy $x 1744-8328 $g Roč. 13, č. 1 (2013), s. 55-61
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23259427 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20150116155412 $b ABA008
- 999 __
- $a ok $b bmc $g 987734 $s 822434
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 13 $c 1 $d 55-61 $i 1744-8328 $m Expert review of anticancer therapy $n Expert Rev Anticancer Ther $x MED00174405
- GRA __
- $a NT11424 $p MZ0
- LZP __
- $a Pubmed-20130703
